Ksawery SzlęZak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ksawery SzlęZak has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anna Dominiczak
Medical University of Warsaw, 02-091 Warszawa, Poland
2 shared publications - Karolina Kryca
Uniwersytet Kardynała Stefana Wyszyńskiego, Warszawa, Poland
2 shared publications - Katarzyna Mazurek
Medical University of Warsaw, 02-091 Warszawa, Poland
2 shared publications - Krzysztof Rogiński
Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, 85-067 Bydgoszcz, Poland
2 shared publications - Marek Wojciechowicz
Medical University of Gdansk
2 shared publications - Marta BrzęCka
Medical University of Warsaw, 02-091 Warszawa, Poland
2 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
APPENDICITIS IN NEONATES (≤28 DAYS OF LIFE): CLINICAL PRESENTATION AND DIAGNOSIS
Neonatal appendicitis is an exceptionally rare condition associated with high morbidity and mortality, primarily due to delayed diagnosis and a nonspecific clinical presentation that overlaps with more common neonatal disorders. The aim of the study: This study aimed to systematically review recently reported cases of neonatal appendicitis with a focus on clinical presentation and diagnostic features. Materials and methods: A systematic review was conducted in accordance with PRISMA guidelines using PubMed and Google Scholar. Fifteen case reports met the inclusion criteria. Results: Abdominal distension was the most frequently reported presenting symptom. Classic signs of acute abdomen were often absent. Laboratory findings were nonspecific and preoperative diagnosis was uncommon. Ultrasonography provided supportive diagnostic information, while pneumoperitoneum on plain radiography often prompted urgent surgical intervention. In most cases, the diagnosis was established intraoperatively, frequently after appendiceal perforation. Conclusions: Neonatal appendicitis presents with nonspecific clinical and diagnostic features that commonly mimic necrotizing enterocolitis. Awareness of abdominal distension as a consistent sign and careful interpretation of imaging findings may support earlier recognition and timely surgical management of this rare but life-threatening condition.
- 30 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessAPPENDICITIS IN NEONATES (≤28 DAYS OF LIFE): CLINICAL PRESENTATION AND DIAGNOSIS
Neonatal appendicitis is an exceptionally rare condition associated with high morbidity and mortality, primarily due to delayed diagnosis and a nonspecific clinical presentation that overlaps with more common neonatal disorders. The aim of the study: This study aimed to systematically review recently reported cases of neonatal appendicitis with a focus on clinical presentation and diagnostic features. Materials and methods: A systematic review was conducted in accordance with PRISMA guidelines using PubMed and Google Scholar. Fifteen case reports met the inclusion criteria. Results: Abdominal distension was the most frequently reported presenting symptom. Classic signs of acute abdomen were often absent. Laboratory findings were nonspecific and preoperative diagnosis was uncommon. Ultrasonography provided supportive diagnostic information, while pneumoperitoneum on plain radiography often prompted urgent surgical intervention. In most cases, the diagnosis was established intraoperatively, frequently after appendiceal perforation. Conclusions: Neonatal appendicitis presents with nonspecific clinical and diagnostic features that commonly mimic necrotizing enterocolitis. Awareness of abdominal distension as a consistent sign and careful interpretation of imaging findings may support earlier recognition and timely surgical management of this rare but life-threatening condition.
- Open Access
- 15 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
LUNG ULTRASOUND IN THE DIAGNOSIS OF MECONIUM ASPIRATION SYNDROME IN NEONATES: A SYSTEMATIC REVIEW
The aim of the study: Meconium aspiration syndrome (MAS) remains an important cause of neonatal respiratory distress and is traditionally diagnosed using clinical criteria supported by chest X-ray. Lung ultrasound (LUS) is a radiation-free, bedside imaging modality increasingly used in neonatal lung diseases. The objective of this systematic review is to evaluate the diagnostic role of LUS in neonates with MAS. Materials and methods: A systematic literature search was conducted in PubMed and Google Scholar in accordance with the PRISMA 2020 guidelines. Original studies involving neonates with MAS and reporting MAS-specific LUS data were included. Studies were excluded if they were non-English, animal studies, lacked original data, involved non-MAS populations or focused on therapy guidance rather than diagnosis. Results: Five studies met the inclusion criteria. Across the included studies, LUS demonstrated high diagnostic performance for MAS, with reported sensitivity ranging from 90% to 100% and specificity 99.3% to 100%. Characteristic LUS findings included lung consolidations with air bronchogram, pleural line abnormalities, disappearance of A-lines and alveolar-interstitial syndrome. Conclusions: LUS appears to be a reliable diagnostic tool for MAS and offers important advantages including absence of ionizing radiation and bedside applicability. It may be considered a first-line imaging modality in infants with suspected MAS, with chest X-ray reserved for cases of diagnostic uncertainty. Further studies are needed to confirm these findings.
- 15 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
Open AccessLUNG ULTRASOUND IN THE DIAGNOSIS OF MECONIUM ASPIRATION SYNDROME IN NEONATES: A SYSTEMATIC REVIEW
The aim of the study: Meconium aspiration syndrome (MAS) remains an important cause of neonatal respiratory distress and is traditionally diagnosed using clinical criteria supported by chest X-ray. Lung ultrasound (LUS) is a radiation-free, bedside imaging modality increasingly used in neonatal lung diseases. The objective of this systematic review is to evaluate the diagnostic role of LUS in neonates with MAS. Materials and methods: A systematic literature search was conducted in PubMed and Google Scholar in accordance with the PRISMA 2020 guidelines. Original studies involving neonates with MAS and reporting MAS-specific LUS data were included. Studies were excluded if they were non-English, animal studies, lacked original data, involved non-MAS populations or focused on therapy guidance rather than diagnosis. Results: Five studies met the inclusion criteria. Across the included studies, LUS demonstrated high diagnostic performance for MAS, with reported sensitivity ranging from 90% to 100% and specificity 99.3% to 100%. Characteristic LUS findings included lung consolidations with air bronchogram, pleural line abnormalities, disappearance of A-lines and alveolar-interstitial syndrome. Conclusions: LUS appears to be a reliable diagnostic tool for MAS and offers important advantages including absence of ionizing radiation and bedside applicability. It may be considered a first-line imaging modality in infants with suspected MAS, with chest X-ray reserved for cases of diagnostic uncertainty. Further studies are needed to confirm these findings.
- Open Access
- 22 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
CURRENT PREVENTION STRATEGIES FOR INFLUENZA VIRUS INFECTION: EVIDENCE, PRACTICE, AND THE ROLE OF MATERNAL VACCINATION
Background: Seasonal influenza remains a major cause of morbidity and mortality in Europe. Prevention relies primarily on vaccination, supported by non-pharmaceutical interventions (NPIs) and surveillance. Pregnant women are a key target group, as maternal immunization protects both mother and infant. Methodology: A narrative review of recent PubMed-indexed studies, complemented by European Centre for Disease Prevention and Control (ECDC) reports and national data from Poland, was undertaken. Evidence on vaccine effectiveness, safety of maternal immunization, vaccination coverage, and the role of NPIs was synthesized. Results: Influenza vaccine effectiveness in Europe has been moderate, ranging from 32–55% depending on subtype and season, with highest protection against influenza B and lowest against A(H3N2). Maternal vaccination provides significant protection for infants under six months, particularly when administered in the third trimester, and shows no association with adverse pregnancy outcomes. Despite strong evidence, vaccine uptake in Poland remains among the lowest in Europe, with only about 10% coverage in older adults and minimal uptake among pregnant women. NPIs, including mask use and hand hygiene, reduce transmission and are particularly valuable in seasons of poor vaccine match. Discussion: Vaccination is the cornerstone of influenza prevention, yet insufficient coverage undermines its impact. Maternal immunization remains underutilized, while NPIs provide important complementary protection. Barriers include cost, misinformation, and logistical challenges. Conclusions: Effective influenza prevention requires higher vaccine uptake, integration of maternal immunization into routine prenatal care, selective use of NPIs, and stronger surveillance. Without systemic improvements, the potential of influenza prevention cannot be fully realized.
- 22 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(47))
Open AccessCURRENT PREVENTION STRATEGIES FOR INFLUENZA VIRUS INFECTION: EVIDENCE, PRACTICE, AND THE ROLE OF MATERNAL VACCINATION
Background: Seasonal influenza remains a major cause of morbidity and mortality in Europe. Prevention relies primarily on vaccination, supported by non-pharmaceutical interventions (NPIs) and surveillance. Pregnant women are a key target group, as maternal immunization protects both mother and infant. Methodology: A narrative review of recent PubMed-indexed studies, complemented by European Centre for Disease Prevention and Control (ECDC) reports and national data from Poland, was undertaken. Evidence on vaccine effectiveness, safety of maternal immunization, vaccination coverage, and the role of NPIs was synthesized. Results: Influenza vaccine effectiveness in Europe has been moderate, ranging from 32–55% depending on subtype and season, with highest protection against influenza B and lowest against A(H3N2). Maternal vaccination provides significant protection for infants under six months, particularly when administered in the third trimester, and shows no association with adverse pregnancy outcomes. Despite strong evidence, vaccine uptake in Poland remains among the lowest in Europe, with only about 10% coverage in older adults and minimal uptake among pregnant women. NPIs, including mask use and hand hygiene, reduce transmission and are particularly valuable in seasons of poor vaccine match. Discussion: Vaccination is the cornerstone of influenza prevention, yet insufficient coverage undermines its impact. Maternal immunization remains underutilized, while NPIs provide important complementary protection. Barriers include cost, misinformation, and logistical challenges. Conclusions: Effective influenza prevention requires higher vaccine uptake, integration of maternal immunization into routine prenatal care, selective use of NPIs, and stronger surveillance. Without systemic improvements, the potential of influenza prevention cannot be fully realized.
- Open Access
- 4 December 2022
- Published by Wiedza Medyczna Centre of Postgraduate Medical Education in Warsaw in Wiedza Medyczna
- Vol. 4 (2) , 6-11
Wewnątrznaczyniowe leczenie zwężeń tętnic przeszczepionej allogenicznej nerki
Recent studies have questioned the effectiveness of surgical treatment of renal artery stenosis. However, patients with artery stenosis of the solitary kidney may benefit most from endovascular therapy. Transplant renal artery stenosis is a cause of organ function deterioration, potentially leading to graft loss and increased mortality in the group of patients affected by this complication. However, we do not have data on the optimal treatment of transplant renal artery stenosis. Therapeutic methods includes conservative treatment and possible qualification for surgical treatment. Performing endovascular intervention offers the chance to correct the stenosis and return proper function to the transplanted kidney. Various methods are used during surgery: angioplasty, and stent implantation, including devices that release local antiproliferative drugs. At present, a timely intervention appears to offer the same chances of long-term graft function and survival as in kidney transplant recipients who do not develop TRAS. Data on epidemiology, risk factors and treatment outcomes are sparse, and further studies are needed. Ostatnie badania kwestionują skuteczność chirurgicznego leczenia zwężenia tętnicy nerkowej. Jednak pacjenci ze zwężeniem tętnicy jedynej nerki mogą odnieść największe korzyści z leczenia wewnątrznaczyniowego. Zwężenie tętnicy nerki przeszczepionej jest przyczyną pogorszenia funkcji narządu, potencjalnie mogącą prowadzić do utraty przeszczepu i zwiększenia śmiertelności w grupie chorych dotkniętych tym powikłaniem. Nie dysponujemy jednak danymi dotyczącymi optymalnego leczenia zwężenia tętnicy nerki przeszczepionej. Obejmuje ono leczenie zachowawcze i ewentualną kwalifikację do leczenia zabiegowego. Przeprowadzenie interwencji wewnątrznaczyniowej daje szansę na korekcję zwężenia i powrót właściwej funkcji nerki przeszczepionej. Podczas operacji wykorzystywane są różne metody - angioplastyka, implantacja stentów, w tym również urządzenia uwalniające miejscowo leki antyproliferacyjne. Obecnie wydaje się, że przeprowadzona w porę interwencja daje takie same szanse na długotrwałe funkcjonowanie przeszczepu i przeżycie, jak w grupie biorców przeszczepu nerki nie rozwijających TRAS. Dane dotyczące epidemiologii, czynników ryzyka i wyników leczenia są skąpe, dlatego potrzebne jest przeprowadzenie dalszych badań.
- 4 December 2022
- Published by Wiedza Medyczna Centre of Postgraduate Medical Education in Warsaw in Wiedza Medyczna
- Vol. 4 (2) , 6-11
Open AccessWewnątrznaczyniowe leczenie zwężeń tętnic przeszczepionej allogenicznej nerki
Recent studies have questioned the effectiveness of surgical treatment of renal artery stenosis. However, patients with artery stenosis of the solitary kidney may benefit most from endovascular therapy. Transplant renal artery stenosis is a cause of organ function deterioration, potentially leading to graft loss and increased mortality in the group of patients affected by this complication. However, we do not have data on the optimal treatment of transplant renal artery stenosis. Therapeutic methods includes conservative treatment and possible qualification for surgical treatment. Performing endovascular intervention offers the chance to correct the stenosis and return proper function to the transplanted kidney. Various methods are used during surgery: angioplasty, and stent implantation, including devices that release local antiproliferative drugs. At present, a timely intervention appears to offer the same chances of long-term graft function and survival as in kidney transplant recipients who do not develop TRAS. Data on epidemiology, risk factors and treatment outcomes are sparse, and further studies are needed. Ostatnie badania kwestionują skuteczność chirurgicznego leczenia zwężenia tętnicy nerkowej. Jednak pacjenci ze zwężeniem tętnicy jedynej nerki mogą odnieść największe korzyści z leczenia wewnątrznaczyniowego. Zwężenie tętnicy nerki przeszczepionej jest przyczyną pogorszenia funkcji narządu, potencjalnie mogącą prowadzić do utraty przeszczepu i zwiększenia śmiertelności w grupie chorych dotkniętych tym powikłaniem. Nie dysponujemy jednak danymi dotyczącymi optymalnego leczenia zwężenia tętnicy nerki przeszczepionej. Obejmuje ono leczenie zachowawcze i ewentualną kwalifikację do leczenia zabiegowego. Przeprowadzenie interwencji wewnątrznaczyniowej daje szansę na korekcję zwężenia i powrót właściwej funkcji nerki przeszczepionej. Podczas operacji wykorzystywane są różne metody - angioplastyka, implantacja stentów, w tym również urządzenia uwalniające miejscowo leki antyproliferacyjne. Obecnie wydaje się, że przeprowadzona w porę interwencja daje takie same szanse na długotrwałe funkcjonowanie przeszczepu i przeżycie, jak w grupie biorców przeszczepu nerki nie rozwijających TRAS. Dane dotyczące epidemiologii, czynników ryzyka i wyników leczenia są skąpe, dlatego potrzebne jest przeprowadzenie dalszych badań.